prev next front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |review
Issues of particular importance to cancer survivors include the risk of recurrence; follow-up care and surveillance for the adverse sequelae of treatment and the development of new cancers, reproductive issues and sequelae in offspring; and quality of life and psychosocial adjustment beyond acute treatment (30,32). Not only do these issues occupy a central core of importance in and of themselves, they also can influence infrastructure systems such as databases, follow-up requirements for clinical trials, new therapeutic approaches, surveillance recommendations and the cancer research agenda itself (10,3335). Decisions concerning needs for specific follow-up care benefit from information derived from studies of the medical and psychological outcomes of both the cancer experience and therapy. Providing information, education and other forms of intervention during active cancer treatment and beyond may have implications for the prevention of future illness and for the overall quality of life of survivors. Cancer survivors are also a rich source of information on consequences of the cancer diagnosis and treatment, such as second cancers and potential comorbidities. (4,10,30)